Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Child

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Hematological Oncology|July 1, 1990
Ifosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's diseaseG J Dovey, J A Child, A V Simmons, et al.
Hematological Oncology|March 5, 1999
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myelomaG Pratt, M E Wiles, A C Rawstron, et al.
Hematological Oncology|January 1, 1994
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin levelD Parker, D L Alison, D L Barnard, et al.
British Journal of Cancer|October 1, 1986
DNA content and prognosis of non-Hodgkin's lymphomaD R Morgan, J M Williamson, P Quirke, et al.
British Journal of Haematology|March 1, 1993
Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: the Yorkshire Leukaemia Group StudyC S Scott, S J Richards, M Sivakumaran, et al.
British Journal of Haematology|August 12, 1999
FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cellsF E Davies, A C Rawstron, G Pratt, et al.
Histopathology|October 1, 1987
Ploidy, proliferative activity, cluster differentiation antigen expression and clinical remission in high-grade non-Hodgkin's lymphomaJ M Williamson, I Grigor, M E Smith, et al.
British Journal of Haematology|May 31, 2001
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expressionA C Rawstron, S L Barrans, D Blythe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG)P H Smith, J A Child, J H Mulder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma--intensive two-phase chemotherapyN S Stuart, G R Blackledge, J A Child, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Hematological Oncology|July 1, 1990
Ifosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's diseaseG J Dovey, J A Child, A V Simmons, et al.
Hematological Oncology|March 5, 1999
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myelomaG Pratt, M E Wiles, A C Rawstron, et al.
Hematological Oncology|January 1, 1994
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin levelD Parker, D L Alison, D L Barnard, et al.
British Journal of Cancer|October 1, 1986
DNA content and prognosis of non-Hodgkin's lymphomaD R Morgan, J M Williamson, P Quirke, et al.
British Journal of Haematology|March 1, 1993
Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: the Yorkshire Leukaemia Group StudyC S Scott, S J Richards, M Sivakumaran, et al.
British Journal of Haematology|August 12, 1999
FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cellsF E Davies, A C Rawstron, G Pratt, et al.
Histopathology|October 1, 1987
Ploidy, proliferative activity, cluster differentiation antigen expression and clinical remission in high-grade non-Hodgkin's lymphomaJ M Williamson, I Grigor, M E Smith, et al.
British Journal of Haematology|May 31, 2001
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expressionA C Rawstron, S L Barrans, D Blythe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG)P H Smith, J A Child, J H Mulder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma--intensive two-phase chemotherapyN S Stuart, G R Blackledge, J A Child, et al.
Pageof 13